University of Pittsburgh School of Medicine Department of Medicine, Division of Pulmonary Allergy and Critical Care Medicine, Pittsburgh, Pennsylvania;
University of Pittsburgh Vascular Medicine Institute, Pittsburgh, Pennsylvania; University of Pittsburgh School of Medicine Department of Pharmacology, Pittsburgh, Pennsylvania;
Am J Physiol Lung Cell Mol Physiol. 2014 Dec 15;307(12):L987-97. doi: 10.1152/ajplung.00063.2014. Epub 2014 Oct 17.
Microvascular barrier integrity is dependent on bioavailable nitric oxide (NO) produced locally by endothelial NO synthase (eNOS). Under conditions of limited substrate or cofactor availability or by enzymatic modification, eNOS may become uncoupled, producing superoxide in lieu of NO. This study was designed to investigate how eNOS-dependent superoxide production contributes to endothelial barrier dysfunction in inflammatory lung injury and its regulation. C57BL/6J mice were challenged with intratracheal LPS. Bronchoalveolar lavage fluid was analyzed for protein accumulation, and lung tissue homogenate was assayed for endothelial NOS content and function. Human lung microvascular endothelial cell (HLMVEC) monolayers were exposed to LPS in vitro, and barrier integrity and superoxide production were measured. Biopterin species were quantified, and coimmunoprecipitation (Co-IP) assays were performed to identify protein interactions with eNOS that putatively drive uncoupling. Mice exposed to LPS demonstrated eNOS-dependent increased alveolar permeability without evidence for altered canonical NO signaling. LPS-induced superoxide production and permeability in HLMVEC were inhibited by the NOS inhibitor nitro-l-arginine methyl ester, eNOS-targeted siRNA, the eNOS cofactor tetrahydrobiopterin, and superoxide dismutase. Co-IP indicated that LPS stimulated the association of eNOS with NADPH oxidase 2 (Nox2), which correlated with augmented eNOS S-glutathionylation both in vitro and in vivo. In vitro, Nox2-specific inhibition prevented LPS-induced eNOS modification and increases in both superoxide production and permeability. These data indicate that eNOS uncoupling contributes to superoxide production and barrier dysfunction in the lung microvasculature after exposure to LPS. Furthermore, the results implicate Nox2-mediated eNOS-S-glutathionylation as a mechanism underlying LPS-induced eNOS uncoupling in the lung microvasculature.
微血管屏障完整性依赖于内皮型一氧化氮合酶 (eNOS) 局部产生的生物可利用的一氧化氮 (NO)。在底物或辅助因子有限的情况下,或者通过酶促修饰,eNOS 可能会失去偶联,产生超氧化物而不是 NO。本研究旨在探讨 eNOS 依赖性超氧化物产生如何导致炎症性肺损伤中的内皮屏障功能障碍及其调节。C57BL/6J 小鼠接受气管内 LPS 挑战。分析支气管肺泡灌洗液中的蛋白积累,并测定肺组织匀浆中的内皮型一氧化氮合酶含量和功能。体外将 LPS 暴露于人肺微血管内皮细胞 (HLMVEC) 单层,测量屏障完整性和超氧化物产生。定量生物喋呤种类,并进行共免疫沉淀 (Co-IP) 测定以鉴定与 eNOS 相互作用的蛋白质,这些蛋白质可能导致解偶联。暴露于 LPS 的小鼠表现出 eNOS 依赖性肺泡通透性增加,而没有证据表明经典 NO 信号发生改变。NOS 抑制剂硝基-L-精氨酸甲酯、eNOS 靶向 siRNA、eNOS 辅助因子四氢生物喋呤和超氧化物歧化酶抑制了 LPS 诱导的 HLMVEC 中超氧化物产生和通透性。Co-IP 表明 LPS 刺激 eNOS 与 NADPH 氧化酶 2 (Nox2) 的结合,这与体外和体内的 eNOS S-谷胱甘肽化增强相关。在体外,Nox2 特异性抑制可防止 LPS 诱导的 eNOS 修饰以及超氧化物产生和通透性的增加。这些数据表明,eNOS 解偶联导致 LPS 暴露后肺微血管中超氧化物产生和屏障功能障碍。此外,结果表明,Nox2 介导的 eNOS-S-谷胱甘肽化是 LPS 诱导的肺微血管中 eNOS 解偶联的机制之一。